CLINICAL_TRIALS
trial_result
· 2023-07-21
Clinical Trial Update: Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine [Phase 3]
Summary
A Phase 3 trial comparing SAR341402 to NovoLog in adults with type 1 diabetes also using insulin glargine has completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2023-07-21